These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 14755031)
21. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection. Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813 [TBL] [Abstract][Full Text] [Related]
22. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Löwhagen GB; Tunbäck P; Andersson K; Bergström T; Johannisson G Sex Transm Infect; 2000 Jun; 76(3):179-82. PubMed ID: 10961194 [TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700 [TBL] [Abstract][Full Text] [Related]
24. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area. LeGoff J; Saussereau E; Boulanger MC; Chemin C; Si-Mohamed A; Bélec L; Maisonneuve L Int J STD AIDS; 2007 Sep; 18(9):593-5. PubMed ID: 17785000 [TBL] [Abstract][Full Text] [Related]
25. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease. Jones CA; Cunningham AL Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632 [TBL] [Abstract][Full Text] [Related]
26. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Mertz GJ; Rosenthal SL; Stanberry LR Sex Transm Dis; 2003 Oct; 30(10):801-2. PubMed ID: 14520182 [No Abstract] [Full Text] [Related]
27. Condom use and the prevention of genital herpes acquisition. Casper C; Wald A Herpes; 2002 Apr; 9(1):10-4. PubMed ID: 11916494 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
29. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. Schiffer JT; Mayer BT; Fong Y; Swan DA; Wald A J R Soc Interface; 2014 Jun; 11(95):20140160. PubMed ID: 24671939 [TBL] [Abstract][Full Text] [Related]
30. An update on short-course episodic and prevention therapies for herpes genitalis. Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886 [TBL] [Abstract][Full Text] [Related]
31. [Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission]. Morand P Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):577-85. PubMed ID: 12122327 [TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial. ; Abu-Elyazeed RR; Heineman T; Dubin G; Fourneau M; Leroux-Roels I; Leroux-Roels G; Richardus JH; Ostergaard L; Diez-Domingo J; Poder A; Van Damme P; Romanowski B; Blatter M; Silfverdal SA; Berglund J; Josefsson A; Cunningham AL; Flodmark CE; Tragiannidis A; Dobson S; Olafsson J; Puig-Barbera J; Mendez M; Barton S; Bernstein D; Mares J; Ratner P Vaccine; 2013 Dec; 31(51):6136-43. PubMed ID: 23850416 [TBL] [Abstract][Full Text] [Related]
33. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Slomka MJ Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192 [TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre. Bassett I; Donovan B; Bodsworth NJ; Field PR; Ho DW; Jeansson S; Cunningham AL Med J Aust; 1994 Jun; 160(11):697-700. PubMed ID: 8202004 [TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066 [TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325 [TBL] [Abstract][Full Text] [Related]
39. Asymptomatic herpes simplex virus type 2 (HSV-2) infection among pregnant women in Turkey. Duran N; Yarkin F; Evruke C; Koksal F Indian J Med Res; 2004 Aug; 120(2):106-10. PubMed ID: 15347860 [TBL] [Abstract][Full Text] [Related]